Navigation Links
Fragile X, Down Syndromes Linked to Faulty Brain Communication,,Stanford Researcher Finds

STANFORD, Calif.--(BUSINESS WIRE)--Apr 10, 2007 - The two most prevalent forms of genetic mental retardation, Fragile X and Down syndromes, may share a common cause, according to researchers at Stanford University School of Medicine. The problem, a crippled communication network in the brain, may also be associated with autism.

Although the genetics of the disorders are very different, the end result for the brain seems to be the same, said Daniel Madison, PhD, associate professor of molecular and cellular physiology. "It's as if you had every light in your house wired to just one or two switches, rather than having many switches that can be flipped on or off in complex combinations to control the lighting in one room," he said.

Madison is the senior author of a paper on Fragile X syndrome in mice, which will be published in the April 11 issue of the Journal of Neuroscience. He published a related study on mice with Down syndrome symptoms in the Feb. 15 issue of the Journal of Physiology.

Madison is a member of Stanford's Down Syndrome Research Center, started in 2003 by researchers at the School of Medicine and Lucile Packard Children's Hospital to accelerate the application of research to effective treatments for the condition.

In the latest study, Madison and postdoctoral scholar Jesse Hanson, PhD, studied Fragile X syndrome, which is a leading cause of mental retardation in this country. Affected people tend to have learning disabilities, distinct physical characteristics such as enlarged ears and a long face, and such behavioral problems as attention deficit disorder, speech disturbances and unusual responses to various sights or sounds. Although it's not known why, about one-third of people with Fragile X also develop autism--a much higher percentage than in the general population. This makes Fragile X, which can be studied in mice, the only genetic model for autism.

As the syn
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Soliris Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
2. Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent
3. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
4. Diabetes Linked to Higher Parkinsons Risk
5. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
6. Stanford Researchers Find Brain Pathway of Depression in Rats
7. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
8. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
9. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
10. Phase 2 Results for EntreMeds Panzem NCD Brain Cancer Study Presented at ASCO
11. Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
Post Your Comments:
(Date:10/30/2014)... -- Stryker Orthopaedics, the Official Joint Replacement Products of ... its debut year of the relationship at the Charles ... This marks the eleventh tournament stop along both ... has activated on-site with the "Stryker Mobility Zone" – ... importance of joint health.  The Stryker ...
(Date:10/30/2014)... Calif. , Oct. 30, 2014  Electronic ... dramatically as a result of government initiatives and ... - healthcare providers have invested over the past ... heart of health IT, and U.S. clinicians use ... Logo - http://photos.prnewswire.com/prnh/20141029/155278LOGO ...
(Date:10/30/2014)... United Kingdom , Oct. 30, 2014 ... (Nasdaq: CBRX ) and Maryland ... drug developers with improved efficiency during clinical development that ... Diego next week. This partnership ... technologies platform, which it launched earlier this month. The ...
Breaking Medicine Technology:Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 2Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 3Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 4Electronic Health Record Usability: CIOs Weigh In 2Electronic Health Record Usability: CIOs Weigh In 3Electronic Health Record Usability: CIOs Weigh In 4Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3
... International Partnership for Microbicides, issued the following statement ... and effectiveness study of BufferGel and PRO2000 (0.5 ... Microbicide Trials Network, a worldwide collaborative group funded ... released final results from its Phase II/IIb safety ...
... Only Approved Platelet Producer in Europe Represents New ... Feb. 6 Amgen (Nasdaq: AMGN ... has granted marketing authorisation for Nplate(R) (romiplostim) for ... thrombocytopenic purpura (ITP) patients who are refractory to ...
Cached Medicine Technology:New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide 2New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide 3New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide 4Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 2Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 3Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 4Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 5Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 6Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 7Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) 8
(Date:10/30/2014)... 2014 Five months after their expansion, ... LLC announces new branding and a website to accompany ... After David Mepham’s promotion to name partner earlier this ... to include Mepham’s name and better reflect their combined ... firm, the decision to implement new branding reflects Hodgkinson ...
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, Oct. ... have been identified that appear linked to autism spectrum ... they are on their way to discovering up to ... Autism spectrum disorders include a range of developmental ... behaviors. An estimated one in 68 U.S. children has ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Global prebiotics ... 2020, according to a new study by Grand View ... surging demand for sugar and fat free products owing ... the demand for prebiotics over the forecast period. , ... , Food & beverage was the largest application ...
(Date:10/30/2014)... TX (PRWEB) October 30, 2014 ... released today its 2014 third quarter infection rates ... Texas boasted infection rates of only two percent ... patient satisfaction scores exceeding 98 percent. , “We ... quarter, which included rising satisfaction scores,” said Robert ...
(Date:10/30/2014)... Dennis Thompson HealthDay Reporter ... milk could be bad for your health, a new study ... milk can help strengthen bones and prevent osteoporosis. These benefits ... milk as part of a healthy diet. But this ... not protect men or women from bone fractures, and was ...
Breaking Medicine News(10 mins):Health News:Hodgkinson Street Mepham Rebrands 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3Health News:Is Milk Your Friend or Foe? 2Health News:Is Milk Your Friend or Foe? 3
... (vitamin C) or its close relative, erythorbate, and the reduced ... have been accompanied by a steep drop in the death ... 10th AACR International Conference on Frontiers in Cancer Prevention Research, ... for colon cancer has apparently not changed much since 1978, ...
... Women living in rural areas face unique challenges concerning health ... rural women are more likely than women living in cities ... form of the disease. "The stage at which the ... of treatment, recovery and survivability," said Faustine Williams, a doctoral ...
... , MONDAY, Oct. 24 (HealthDay News) -- Yoga instruction ... discomfort from chronic moderate lower-back pain, new research suggests. ... pain on your own by following the exercise, lifestyle ... found. "For a person with garden-variety back pain ...
... MONDAY, Oct. 24 (HealthDay News) -- For the millions of ... taking the pills at bedtime may be best. It ... of the day can affect patients, blood pressure patterns, but ... study included 661 patients with chronic kidney disease and hypertension. ...
... breast cancer survival rates found that the probability that a ... death because of screening mammography may be lower than previously ... Archives of Internal Medicine , one of the JAMA/Archives journals. ... survivor than ever before," the authors write. "Between 1971 and ...
... HealthDay Reporter , MONDAY, Oct. 24 (HealthDay News) -- ... (BPA) while in their mother,s womb may be more likely ... new research finds. BPA is a chemical widely used ... mothers gave urine samples that were tested for BPA while ...
Cached Medicine News:Health News:Could additives in hot dogs affect incidence of colon cancer? 2Health News:Rural women more likely to be diagnosed with most serious form of breast cancer 2Health News:Yoga, Stretching Classes Outdo Self-Care for Back Pain: Study 2Health News:Yoga, Stretching Classes Outdo Self-Care for Back Pain: Study 3Health News:Taking Blood Pressure Meds at Bedtime May Be Better 2Health News:Probability model estimates proportion of women who survive breast cancer detected through screening 2Health News:Probability model estimates proportion of women who survive breast cancer detected through screening 3Health News:Probability model estimates proportion of women who survive breast cancer detected through screening 4Health News:BPA Exposure in Womb Linked to Behavioral Woes in Girls 2Health News:BPA Exposure in Womb Linked to Behavioral Woes in Girls 3
Iron / TIBC (Ferrozine). Storage temp: 2 - 8 C. Linearity: 0 - 500 ug/dl. Expected values: from TIBC 250 - 400 ug/dl, from Iron 40 - 160 ug/dl. Available with Calibrator and Number of test are 100....
For the quantitative determination of iron, total iron-binding capacity in human serum....
HDL Cholesterol, liquid....
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...
Medicine Products: